Articles

Super Micro’s stock rallies after Nasdaq extends the deadline for financial filings, but the stock is still being weighed down by an accounting overhang.

AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said it’s on track to seek approval for the drug from the Food and Drug Administration in 2025.

A pair of big-money acquisitions by advertising company Omnicom and insurance broker Arthur J. Gallagher tip the scales at a combined $27 billion.

A BofA analyst downgraded AMD’s stock, warning of limitations on the company’s ability to pick up share in an AI market dominated by Nvidia.

The social-media platform is expanding its beta test of Reddit Answers, the company said Monday.

Oppenheimer Asset Management’s chief investment strategist, John Stoltzfus, predicts the S&P 500 will reach 7,100 in 2025, thanks in part to a resilient economy.

Barclays upgrades Robinhood and Schwab to overweight from equal-weight as analyst sees “constructive” trading backdrop in 2025.

Some investing pros study the past. Others look ahead. Why it’s important to do both.

Two of the company’s investors launched a campaign Monday seeking changes at Macy’s that would boost profitability and returns.

Nvidia’s stock heads for a third-straight decline after report of China’s investigation due to antitrust concerns.

Your best stock-market advice for 2025? Pay no attention to stock-market predictions, which are frequently — and comically — wrong.

The biggest cause of the housing crisis is a lack of inventory, and building more homes is clearly a critical part of the equation.